What is MEDROXYPROGESTERONE ACETATE used for?

MEDROXYPROGESTERONE ACETATE (brand name MEDROXYPROGESTERONE ACETATE) is a Hormone indicated for longer than 2 years) birth control method unless other options are considered inadequate. (1, 5.1).

What are the most common side effects of MEDROXYPROGESTERONE ACETATE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for MEDROXYPROGESTERONE ACETATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is MEDROXYPROGESTERONE ACETATE the same as MEDROXYPROGESTERONE ACETATE?

MEDROXYPROGESTERONE ACETATE is a brand name for MEDROXYPROGESTERONE ACETATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

MEDROXYPROGESTERONE ACETATE

Q: How does MEDROXYPROGESTERONE ACETATE work?

MEDROXYPROGESTERONE ACETATE works through the following mechanism: 12.1 Mechanism of Action Medroxyprogesterone acetate (MPA) injectable suspension, inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of cervical mucus. These actions contribute to its contraceptive effect..

Hormone

Brand names: MEDROXYPROGESTERONE ACETATE

Intramuscular

Mechanism of Action

12.1 Mechanism of Action Medroxyprogesterone acetate (MPA) injectable suspension, inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening of cervical mucus. These actions contribute to its contraceptive effect.

Indications

longer than 2 years) birth control method unless other options are considered inadequate. (1

5.1)

Contraindications

• or current or past history of thromboembolic disorders
• or current or past history of thromboembolic disorders

FDA Warnings

5 WARNINGS AND PRECAUTIONS Thromboembolic Disorders: Discontinue medroxyprogesterone acetate injectable suspension in patients who develop thrombosis
2 ) Cancer Risks: Monitor women with a strong family history of breast cancer carefully
It is unknown if use of medroxyprogesterone acetate injectable suspension by younger women will reduce peak bone mass and increase the risk for osteoporotic fracture in later life
Other birth control methods should be considered in the risk/benefit analysis for the use of medroxyprogesterone acetate injectable suspension in women with osteoporosis risk factors

Known Side Effects

9 documented side effects by frequency

Drug Not Working

0.1-1%

Nausea

0.1-1%

Headache

0.1-1%

Depression

0.1-1%

Fatigue

0.1-1%

Anxiety

0.1-1%

Weight Gain

0.1-1%

Dizziness

0.1-1%

Shortness of Breath

0.1-1%

Community Discussions

No community discussions found for MEDROXYPROGESTERONE ACETATE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → MEDROXYPROGESTERONE ACETATE openFDA label JSON → MEDROXYPROGESTERONE ACETATE FAERS adverse-event reports → MEDROXYPROGESTERONE ACETATE ClinicalTrials.gov → completed Phase 2+ trials of MEDROXYPROGESTERONE ACETATE

Compare With

15 available comparisons

Formulations

Dosage Forms

Tablet

Route

Intramuscular